ロード中...
A randomized phase II study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer
BACKGROUND: Use of radiopharmaceutical may improve the survival time of patients with castrate-resistant prostate cancer and bone metastases. Whether androgen-deprivation therapy (ADT) combined with bone-targeted therapy provides clinical benefit for patients with advanced castrate-sensitive prostat...
保存先:
| 出版年: | Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4270821/ https://ncbi.nlm.nih.gov/pubmed/25155428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28971 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|